|
Market Closed -
Nasdaq
00:00:00 28/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 78.56 USD | -0.01% |
|
-8.37% | +18.37% |
| 10-26 | Leerink Partners Adjusts Price Target on DexCom to $87 From $94 | MT |
| 10-16 | HEALTH ROUNDS-Glucose monitoring devices for type 2 diabetes benefit even those not on insulin | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DEXCOM, INC. | Other Medical Equipment, Supplies & Distribution | -0.01% | -8.37% | +18.37% | +11.23% | -43.74% | 29.65B |  |  | |
- Stock Market
- Stocks
- DXCM Stock
- Charts DexCom, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
